Integran Technologies Enters into Market Development Agreement with Magnetic Shield

Integran Technologies Inc. today announced that it has entered into a Market Development Agreement (MDA) with Magnetic Shield Corporation (Bensenville, IL) to accelerate market penetration of Integran's Nanovate EM coating for low frequency magnetic shielding.

Integran's NanovateTM EM coating process achieves similar performance to specialty discrete magnetic shielding foils, but uses a process that allows a nanocrystalline metal to be applied directly to metal, polymer and composite substrates. The process flexibility enables applications where part size, and/or complexity makes the use of formed foils impractical. In addition, the NanovateTM EM coating also eliminates additional processes such as forming, annealing and assembly. "We see tremendous promise in the Nanovate EM coating when considering the decreasing size and increasing complexity of certain part applications.", says Mark Wickler, COO of Magnetic Shield Corporation.

The agreement is expected to leverage Magnetic Shield Corporation's wealth of knowledge and extensive customer base, built over 68 years of business, to find existing and new applications where the NanovateTM EM coating would be an effective and elegant solution. "We are excited about the MDA with Magnetic Shield Corporation as they have demonstrated themselves to be market leaders in the magnetic shielding industry, both from a material supply and an application support perspective.", says Rich Emrich, VP Business Development at Integran.

Integran and Magnetic Shield Corporation expect interest from customers working with sensors, transducers, and other electronic devices sensitive to low frequency magnetic interference to be particularly interested in this novel approach.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.